ALEMTUZUMAB for Immune tolerance induction: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where ALEMTUZUMAB was used for Immune tolerance induction.
Most Reported Side Effects for ALEMTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 1,808 | 12.8% | 44 | 700 |
| Fatigue | 1,744 | 12.3% | 30 | 640 |
| Pyrexia | 1,441 | 10.2% | 114 | 837 |
| Off label use | 1,259 | 8.9% | 275 | 274 |
| Rash | 1,094 | 7.7% | 28 | 387 |
| Nausea | 1,053 | 7.4% | 28 | 424 |
| Dyspnoea | 855 | 6.0% | 44 | 425 |
| Lymphocyte count decreased | 852 | 6.0% | 15 | 259 |
| Asthenia | 841 | 5.9% | 29 | 422 |
| Multiple sclerosis relapse | 836 | 5.9% | 14 | 391 |
| Urinary tract infection | 746 | 5.3% | 36 | 420 |
| Drug ineffective | 715 | 5.1% | 139 | 219 |
| Pain | 705 | 5.0% | 15 | 290 |
| Condition aggravated | 623 | 4.4% | 42 | 276 |
| Malaise | 621 | 4.4% | 24 | 279 |
Other Indications for ALEMTUZUMAB
Multiple sclerosis (4,389)
Relapsing-remitting multiple sclerosis (1,604)
Bone marrow conditioning regimen (1,122)
Immunosuppressant drug therapy (594)
Product used for unknown indication (416)
Relapsing multiple sclerosis (350)
Chronic lymphocytic leukaemia (315)
Prophylaxis against graft versus host disease (277)
Immunosuppression (261)
Stem cell transplant (235)
Other Drugs Used for Immune tolerance induction
RITUXIMAB (207)
HUMAN IMMUNOGLOBULIN G (88)
ASPIRIN (62)
MYCOPHENOLATE MOFETIL (62)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (53)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (52)
EFMOROCTOCOG ALFA (46)
PHLEUM PRATENSE POLLEN (36)
BORTEZOMIB (35)
OXALIPLATIN (33)